Er Kang Pharmaceuticals (300267.SZ): Sodium hydroxide API market application approved.

Financial and Economic News from Zhi Tong: Erkang Pharmaceuticals (300267.SZ) announced that the company recently received the "Approval Notice for the Marketing Application of Sodium Hydroxide Raw Materials for Chemical Raw Materials" issued by the National Medical Products Administration. Sodium hydroxide is a pH regulator drug. This approval further enriches the company's raw material variety and helps improve the company's product market competitiveness, bringing positive effects to the future market expansion and sales of the above-mentioned products.